EOI: Innovative Clinical Trials in Type 1 Diabetes

Agency: 
JDRF/ITN

The current EOI is targeted towards the identification of novel and important clinical trial ideas, rather than detailed scientific treatments of the precise methodologies. As such, the EOI aims to gather information about the scientific basis for the innovative project, and its implications in terms of clinical benefit and our understanding of tolerance. Of particular interest to the JDRF-ITN
Partnerships are projects that hold significant potential to increase our understanding of, and our ability to induce and maintain a state of clinical tolerance in autoimmune diabetes.

Deadline: 
April 13, 2009

Last updated March 19, 2009